Substantial effort has focused on the development of novel targeted agents for treating patients with late-stage colorectal carcinoma. These agents are designed specifically to inhibit biochemical processes associated with pathogenesis. Numerous molecules targeting the epidermal growth factor receptor have been investigated as therapeutic agents and appear to herald a shift in the treatment paradigm for colorectal carcinoma. © 2005 American Cancer Society.
CITATION STYLE
Venook, A. P. (2005, June 15). Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma. Cancer. https://doi.org/10.1002/cncr.21123
Mendeley helps you to discover research relevant for your work.